Ralph Craven

CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.

CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.

CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.

CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.

Arrow Energy Pty Ltd. explores, develops, and produces coal seam gas (CSG). The firm produces CSG from fields in the Surat Basin and Bowen Basin. It also supplies power stations such as the Townsville, Daandine, Braemar, Braemar 2, and Moranbah. The company was founded in 1997 and is headquartered in Brisbane, Australia.

Ergon Energy Corp. Ltd. distributes, retails and generates electricity to homes and businesses in regional Queensland. It also maintains and manages the regional Queensland electricity network. The firm’s electricity network consists of power lines and power poles, along with associated infrastructure such as major substations and power transformer. The company was founded in 1999 and is headquartered in Townsville, Australia.

CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.

CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.

Ergon Energy Corp. Ltd. distributes, retails and generates electricity to homes and businesses in regional Queensland. It also maintains and manages the regional Queensland electricity network. The firm’s electricity network consists of power lines and power poles, along with associated infrastructure such as major substations and power transformer. The company was founded in 1999 and is headquartered in Townsville, Australia.

Ergon Energy Corp. Ltd. distributes, retails and generates electricity to homes and businesses in regional Queensland. It also maintains and manages the regional Queensland electricity network. The firm’s electricity network consists of power lines and power poles, along with associated infrastructure such as major substations and power transformer. The company was founded in 1999 and is headquartered in Townsville, Australia.

Ergon Energy Corp. Ltd. distributes, retails and generates electricity to homes and businesses in regional Queensland. It also maintains and manages the regional Queensland electricity network. The firm’s electricity network consists of power lines and power poles, along with associated infrastructure such as major substations and power transformer. The company was founded in 1999 and is headquartered in Townsville, Australia.

Ergon Energy Corp. Ltd. distributes, retails and generates electricity to homes and businesses in regional Queensland. It also maintains and manages the regional Queensland electricity network. The firm’s electricity network consists of power lines and power poles, along with associated infrastructure such as major substations and power transformer. The company was founded in 1999 and is headquartered in Townsville, Australia.

Transpower New Zealand Ltd. engaged in the management and operation of electric power transmission in New Zealand. It operates the National Grid, a physical link between generators, local lines businesses, and direct connect customers. The company was founded in 1994 and is headquartered in Wellington, New Zealand.

Arrow Energy Pty Ltd. explores, develops, and produces coal seam gas (CSG). The firm produces CSG from fields in the Surat Basin and Bowen Basin. It also supplies power stations such as the Townsville, Daandine, Braemar, Braemar 2, and Moranbah. The company was founded in 1997 and is headquartered in Brisbane, Australia.

CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.

Transpower New Zealand Ltd. engaged in the management and operation of electric power transmission in New Zealand. It operates the National Grid, a physical link between generators, local lines businesses, and direct connect customers. The company was founded in 1994 and is headquartered in Wellington, New Zealand.

CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.

CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.

Stanwell Corp. Ltd. owns coal, gas and water assets which is used in generating in electricity. It has power stations in terms of asset age, fuel source and location. The firm sells electricity through retail business. It has customers in Queensland, New South Wales the ACT and Victoria. The company was founded on July 1, 1997 and is headquartered in Brisbane, Australia.